The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intestinal Ascariasis Medicine Market Research Report 2025
Synopsis
Intestinal ascariasis is an infection of the small intestine caused by lumbricoides, which is a species of roundworm.
The global Intestinal Ascariasis Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intestinal Ascariasis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intestinal Ascariasis Medicine.
Report Scope
The Intestinal Ascariasis Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intestinal Ascariasis Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intestinal Ascariasis Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries
Segment by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others
Segment by Application
Patients With Ulcer Disease
Complication Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intestinal Ascariasis Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Intestinal ascariasis is an infection of the small intestine caused by lumbricoides, which is a species of roundworm.
The global Intestinal Ascariasis Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intestinal Ascariasis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intestinal Ascariasis Medicine.
Report Scope
The Intestinal Ascariasis Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intestinal Ascariasis Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intestinal Ascariasis Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Actavis
Henan Sino New Energy Material
Bayer HealthCare
Bullvet
Inject Care Parenterals
Endo Pharmaceuticals
Sanofi
Purdue Pharma
Novartis
Johnson & Johnson
Cipla
Sun Pharmaceutical Industries
Segment by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others
Segment by Application
Patients With Ulcer Disease
Complication Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intestinal Ascariasis Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Painkiller
1.2.3 Piperazine Citrate
1.2.4 Complication Treatment Drug
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intestinal Ascariasis Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Patients With Ulcer Disease
1.3.3 Complication Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intestinal Ascariasis Medicine Market Perspective (2019-2030)
2.2 Intestinal Ascariasis Medicine Growth Trends by Region
2.2.1 Global Intestinal Ascariasis Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Intestinal Ascariasis Medicine Historic Market Size by Region (2019-2024)
2.2.3 Intestinal Ascariasis Medicine Forecasted Market Size by Region (2025-2030)
2.3 Intestinal Ascariasis Medicine Market Dynamics
2.3.1 Intestinal Ascariasis Medicine Industry Trends
2.3.2 Intestinal Ascariasis Medicine Market Drivers
2.3.3 Intestinal Ascariasis Medicine Market Challenges
2.3.4 Intestinal Ascariasis Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intestinal Ascariasis Medicine Players by Revenue
3.1.1 Global Top Intestinal Ascariasis Medicine Players by Revenue (2019-2024)
3.1.2 Global Intestinal Ascariasis Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Intestinal Ascariasis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intestinal Ascariasis Medicine Revenue
3.4 Global Intestinal Ascariasis Medicine Market Concentration Ratio
3.4.1 Global Intestinal Ascariasis Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intestinal Ascariasis Medicine Revenue in 2023
3.5 Intestinal Ascariasis Medicine Key Players Head office and Area Served
3.6 Key Players Intestinal Ascariasis Medicine Product Solution and Service
3.7 Date of Enter into Intestinal Ascariasis Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intestinal Ascariasis Medicine Breakdown Data by Type
4.1 Global Intestinal Ascariasis Medicine Historic Market Size by Type (2019-2024)
4.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Type (2025-2030)
5 Intestinal Ascariasis Medicine Breakdown Data by Application
5.1 Global Intestinal Ascariasis Medicine Historic Market Size by Application (2019-2024)
5.2 Global Intestinal Ascariasis Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Intestinal Ascariasis Medicine Market Size (2019-2030)
6.2 North America Intestinal Ascariasis Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Intestinal Ascariasis Medicine Market Size by Country (2019-2024)
6.4 North America Intestinal Ascariasis Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intestinal Ascariasis Medicine Market Size (2019-2030)
7.2 Europe Intestinal Ascariasis Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Intestinal Ascariasis Medicine Market Size by Country (2019-2024)
7.4 Europe Intestinal Ascariasis Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intestinal Ascariasis Medicine Market Size (2019-2030)
8.2 Asia-Pacific Intestinal Ascariasis Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intestinal Ascariasis Medicine Market Size (2019-2030)
9.2 Latin America Intestinal Ascariasis Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Intestinal Ascariasis Medicine Market Size by Country (2019-2024)
9.4 Latin America Intestinal Ascariasis Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intestinal Ascariasis Medicine Market Size (2019-2030)
10.2 Middle East & Africa Intestinal Ascariasis Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Intestinal Ascariasis Medicine Introduction
11.1.4 Pfizer Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Actavis
11.2.1 Actavis Company Detail
11.2.2 Actavis Business Overview
11.2.3 Actavis Intestinal Ascariasis Medicine Introduction
11.2.4 Actavis Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.2.5 Actavis Recent Development
11.3 Henan Sino New Energy Material
11.3.1 Henan Sino New Energy Material Company Detail
11.3.2 Henan Sino New Energy Material Business Overview
11.3.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Introduction
11.3.4 Henan Sino New Energy Material Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.3.5 Henan Sino New Energy Material Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Detail
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Intestinal Ascariasis Medicine Introduction
11.4.4 Bayer HealthCare Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.4.5 Bayer HealthCare Recent Development
11.5 Bullvet
11.5.1 Bullvet Company Detail
11.5.2 Bullvet Business Overview
11.5.3 Bullvet Intestinal Ascariasis Medicine Introduction
11.5.4 Bullvet Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.5.5 Bullvet Recent Development
11.6 Inject Care Parenterals
11.6.1 Inject Care Parenterals Company Detail
11.6.2 Inject Care Parenterals Business Overview
11.6.3 Inject Care Parenterals Intestinal Ascariasis Medicine Introduction
11.6.4 Inject Care Parenterals Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.6.5 Inject Care Parenterals Recent Development
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Detail
11.7.2 Endo Pharmaceuticals Business Overview
11.7.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Introduction
11.7.4 Endo Pharmaceuticals Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.7.5 Endo Pharmaceuticals Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Intestinal Ascariasis Medicine Introduction
11.8.4 Sanofi Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Purdue Pharma
11.9.1 Purdue Pharma Company Detail
11.9.2 Purdue Pharma Business Overview
11.9.3 Purdue Pharma Intestinal Ascariasis Medicine Introduction
11.9.4 Purdue Pharma Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.9.5 Purdue Pharma Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Intestinal Ascariasis Medicine Introduction
11.10.4 Novartis Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Introduction
11.11.4 Johnson & Johnson Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.11.5 Johnson & Johnson Recent Development
11.12 Cipla
11.12.1 Cipla Company Detail
11.12.2 Cipla Business Overview
11.12.3 Cipla Intestinal Ascariasis Medicine Introduction
11.12.4 Cipla Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.12.5 Cipla Recent Development
11.13 Sun Pharmaceutical Industries
11.13.1 Sun Pharmaceutical Industries Company Detail
11.13.2 Sun Pharmaceutical Industries Business Overview
11.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Introduction
11.13.4 Sun Pharmaceutical Industries Revenue in Intestinal Ascariasis Medicine Business (2019-2024)
11.13.5 Sun Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Painkiller
Table 3. Key Players of Piperazine Citrate
Table 4. Key Players of Complication Treatment Drug
Table 5. Key Players of Others
Table 6. Global Intestinal Ascariasis Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Intestinal Ascariasis Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Intestinal Ascariasis Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Intestinal Ascariasis Medicine Market Share by Region (2019-2024)
Table 10. Global Intestinal Ascariasis Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Intestinal Ascariasis Medicine Market Share by Region (2025-2030)
Table 12. Intestinal Ascariasis Medicine Market Trends
Table 13. Intestinal Ascariasis Medicine Market Drivers
Table 14. Intestinal Ascariasis Medicine Market Challenges
Table 15. Intestinal Ascariasis Medicine Market Restraints
Table 16. Global Intestinal Ascariasis Medicine Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Intestinal Ascariasis Medicine Market Share by Players (2019-2024)
Table 18. Global Top Intestinal Ascariasis Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intestinal Ascariasis Medicine as of 2023)
Table 19. Ranking of Global Top Intestinal Ascariasis Medicine Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Intestinal Ascariasis Medicine Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Intestinal Ascariasis Medicine Product Solution and Service
Table 23. Date of Enter into Intestinal Ascariasis Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intestinal Ascariasis Medicine Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2019-2024)
Table 27. Global Intestinal Ascariasis Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2025-2030)
Table 29. Global Intestinal Ascariasis Medicine Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2019-2024)
Table 31. Global Intestinal Ascariasis Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2025-2030)
Table 33. North America Intestinal Ascariasis Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Intestinal Ascariasis Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Intestinal Ascariasis Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Intestinal Ascariasis Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Intestinal Ascariasis Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Intestinal Ascariasis Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Intestinal Ascariasis Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Intestinal Ascariasis Medicine Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Intestinal Ascariasis Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Intestinal Ascariasis Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Intestinal Ascariasis Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Intestinal Ascariasis Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2025-2030) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Intestinal Ascariasis Medicine Product
Table 51. Pfizer Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Actavis Company Detail
Table 54. Actavis Business Overview
Table 55. Actavis Intestinal Ascariasis Medicine Product
Table 56. Actavis Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 57. Actavis Recent Development
Table 58. Henan Sino New Energy Material Company Detail
Table 59. Henan Sino New Energy Material Business Overview
Table 60. Henan Sino New Energy Material Intestinal Ascariasis Medicine Product
Table 61. Henan Sino New Energy Material Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 62. Henan Sino New Energy Material Recent Development
Table 63. Bayer HealthCare Company Detail
Table 64. Bayer HealthCare Business Overview
Table 65. Bayer HealthCare Intestinal Ascariasis Medicine Product
Table 66. Bayer HealthCare Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 67. Bayer HealthCare Recent Development
Table 68. Bullvet Company Detail
Table 69. Bullvet Business Overview
Table 70. Bullvet Intestinal Ascariasis Medicine Product
Table 71. Bullvet Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 72. Bullvet Recent Development
Table 73. Inject Care Parenterals Company Detail
Table 74. Inject Care Parenterals Business Overview
Table 75. Inject Care Parenterals Intestinal Ascariasis Medicine Product
Table 76. Inject Care Parenterals Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 77. Inject Care Parenterals Recent Development
Table 78. Endo Pharmaceuticals Company Detail
Table 79. Endo Pharmaceuticals Business Overview
Table 80. Endo Pharmaceuticals Intestinal Ascariasis Medicine Product
Table 81. Endo Pharmaceuticals Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 82. Endo Pharmaceuticals Recent Development
Table 83. Sanofi Company Detail
Table 84. Sanofi Business Overview
Table 85. Sanofi Intestinal Ascariasis Medicine Product
Table 86. Sanofi Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Purdue Pharma Company Detail
Table 89. Purdue Pharma Business Overview
Table 90. Purdue Pharma Intestinal Ascariasis Medicine Product
Table 91. Purdue Pharma Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 92. Purdue Pharma Recent Development
Table 93. Novartis Company Detail
Table 94. Novartis Business Overview
Table 95. Novartis Intestinal Ascariasis Medicine Product
Table 96. Novartis Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Johnson & Johnson Company Detail
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Intestinal Ascariasis Medicine Product
Table 101. Johnson & Johnson Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. Cipla Company Detail
Table 104. Cipla Business Overview
Table 105. Cipla Intestinal Ascariasis Medicine Product
Table 106. Cipla Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 107. Cipla Recent Development
Table 108. Sun Pharmaceutical Industries Company Detail
Table 109. Sun Pharmaceutical Industries Business Overview
Table 110. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product
Table 111. Sun Pharmaceutical Industries Revenue in Intestinal Ascariasis Medicine Business (2019-2024) & (US$ Million)
Table 112. Sun Pharmaceutical Industries Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intestinal Ascariasis Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Intestinal Ascariasis Medicine Market Share by Type: 2023 VS 2030
Figure 3. Painkiller Features
Figure 4. Piperazine Citrate Features
Figure 5. Complication Treatment Drug Features
Figure 6. Others Features
Figure 7. Global Intestinal Ascariasis Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Intestinal Ascariasis Medicine Market Share by Application: 2023 VS 2030
Figure 9. Patients With Ulcer Disease Case Studies
Figure 10. Complication Treatment Case Studies
Figure 11. Others Case Studies
Figure 12. Intestinal Ascariasis Medicine Report Years Considered
Figure 13. Global Intestinal Ascariasis Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Intestinal Ascariasis Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Intestinal Ascariasis Medicine Market Share by Region: 2023 VS 2030
Figure 16. Global Intestinal Ascariasis Medicine Market Share by Players in 2023
Figure 17. Global Top Intestinal Ascariasis Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intestinal Ascariasis Medicine as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Intestinal Ascariasis Medicine Revenue in 2023
Figure 19. North America Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Intestinal Ascariasis Medicine Market Share by Country (2019-2030)
Figure 21. United States Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Intestinal Ascariasis Medicine Market Share by Country (2019-2030)
Figure 25. Germany Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Intestinal Ascariasis Medicine Market Share by Region (2019-2030)
Figure 33. China Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Intestinal Ascariasis Medicine Market Share by Country (2019-2030)
Figure 41. Mexico Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Intestinal Ascariasis Medicine Market Share by Country (2019-2030)
Figure 45. Turkey Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Intestinal Ascariasis Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 48. Actavis Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 49. Henan Sino New Energy Material Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 50. Bayer HealthCare Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 51. Bullvet Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 52. Inject Care Parenterals Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 53. Endo Pharmaceuticals Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 54. Sanofi Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 55. Purdue Pharma Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 57. Johnson & Johnson Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 58. Cipla Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 59. Sun Pharmaceutical Industries Revenue Growth Rate in Intestinal Ascariasis Medicine Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
